Prosecution Insights
Last updated: October 02, 2026

Examiner: GANESAN, SUBA

Tech Center 3700 • Art Units: 3686 3774

This examiner grants 74% of resolved cases

Analysis

Suba Ganesan is an examiner in Tech Center 3700 and Art Unit 3686. With 682 resolved cases, Ganesan has an allowance rate of 73.8 percent. This 73.8 percent allowance rate suggests a favorable probability of success for applicants. The volume of 682 resolved cases provides a robust statistical foundation for these performance metrics.

The data shows an interview lift of 13.4 percent. This 13.4 percent lift indicates that conducting an interview with the examiner is associated with a higher likelihood of allowance compared to cases without an interview. Practitioners can use this information to justify the time and expense of an interview to their clients. The 13.4 percent lift suggests that direct communication is a useful tactic for resolving issues in Art Unit 3686.

The median time to allowance is 1219 days. This 1219 day period is the typical duration from filing to patent issuance. Applicants should factor this 1219 day median into their prosecution budgets and expectations. With 682 resolved cases, this timing metric is a reliable indicator of the examiner's typical pace.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

73.8%
Allow Rate
+3.8% vs TC avg
718
Total Applications
+13.4%
Interview Lift
1219
Avg Prosecution Days
Based on 682 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
22.5%
§102 Novelty
49.8%
§103 Obviousness
20.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18411695 STENT-VALVES FOR VALVE REPLACEMENT AND ASSOCIATED METHODS AND SYSTEMS FOR SURGERY Final Rejection Boston Scientific Medical Device Limited
19540505 DEVICES, SYSTEMS, AND METHODS FOR AN IMPLANTABLE HEART-VALVE ADAPTER Non-Final OA ReValve Solutions, Inc.
19346566 Devices, Systems, and Methods for an Implantable Heart-Valve Adapter Non-Final OA ReValve Solutions, Inc.
18422384 PROSTHETIC VALVES WITH MECHANISMS FOR CONTROLLED EXPANSION Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18448726 PROSTHETIC VALVES Non-Final OA EDWARDS LIFESCIENCES CORPORATION
18181521 COMPRESSIBLE SHUNT IMPLANT Final Rejection EDWARDS LIFESCIENCES CORPORATION
17826029 PROSTHETIC HEART VALVES WITH COMMISSURE POST PROTRUSIONS FOR COMMISSURE ASSEMBLY POSITION LOCKING Final Rejection Edwards Lifesciences Corporation
18812211 METHODS AND APPARATUS FOR PREDICTING DECOUPLING DURING NON-CARDIAC MEDICAL PROCEDURES Non-Final OA Abiomed, Inc.
18035913 SYSTEMS AND METHODS FOR MANUFACTURING PROSTHETIC HEART VALVES USING A SINGLE-PIECE VALVE SUBASSEMBLY Non-Final OA Medtronic, Inc.
17849565 BIOHYBRID HEART VALVE REPLACEMENT Final Rejection THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
18043480 PROSTHETIC CARDIAC VALVE DELIVERY SYSTEMS AND METHODS Final Rejection SHIFAMED HOLDINGS, LLC
18441543 Fibrosis Model On A Chip Non-Final OA The Trustees of the University of Pennsylvania
18035509 TRANSCATHETER DEVICE FOR TREATING TRICUSPID VALVE REGURGITATION Final Rejection TAU MEDICAL INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month